Supernus Pharmaceuticals, Inc. (SUPN)
29.72
+0.52
(+1.78%)
USD |
NASDAQ |
Nov 13, 16:00
29.30
-0.42
(-1.41%)
After-Hours: 19:59
Supernus Pharmaceuticals Market Cap : 1.731B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.731B |
| November 12, 2026 | 1.701B |
| November 11, 2026 | 1.716B |
| November 10, 2026 | 1.675B |
| November 09, 2026 | 1.609B |
| November 06, 2026 | 1.524B |
| November 05, 2026 | 1.558B |
| November 04, 2026 | 1.643B |
| November 03, 2026 | 1.640B |
| November 02, 2026 | 2.113B |
| October 30, 2026 | 2.442B |
| October 29, 2026 | 2.437B |
| October 28, 2026 | 2.393B |
| October 27, 2026 | 2.386B |
| October 26, 2026 | 2.375B |
| October 23, 2026 | 2.371B |
| October 22, 2026 | 2.451B |
| October 21, 2026 | 2.401B |
| October 20, 2026 | 2.402B |
| October 19, 2026 | 2.321B |
| October 16, 2026 | 2.207B |
| October 15, 2026 | 2.305B |
| October 14, 2026 | 2.341B |
| October 13, 2026 | 2.447B |
| October 12, 2026 | 2.494B |
| Date | Value |
|---|---|
| October 09, 2026 | 2.486B |
| October 08, 2026 | 2.455B |
| October 07, 2026 | 2.508B |
| October 06, 2026 | 2.495B |
| October 05, 2026 | 2.491B |
| October 02, 2026 | 2.469B |
| October 01, 2026 | 2.457B |
| September 30, 2026 | 2.507B |
| September 29, 2026 | 2.557B |
| September 28, 2026 | 2.594B |
| September 25, 2026 | 2.481B |
| September 24, 2026 | 2.518B |
| September 23, 2026 | 2.524B |
| September 22, 2026 | 2.545B |
| September 21, 2026 | 2.488B |
| September 18, 2026 | 2.443B |
| September 17, 2026 | 2.496B |
| September 16, 2026 | 2.407B |
| September 15, 2026 | 2.401B |
| September 14, 2026 | 2.413B |
| September 11, 2026 | 2.422B |
| September 10, 2026 | 2.425B |
| September 09, 2026 | 2.447B |
| September 08, 2026 | 2.468B |
| September 04, 2026 | 2.532B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.636B |
| Prestige Consumer Healthcare, Inc. | 2.189B |
| Structure Therapeutics, Inc. | 1.427B |
| Corcept Therapeutics, Inc. | 7.977B |
| Veru, Inc. | 35.64M |
Market Cap Related Metrics
| PS Ratio | 1.997 |
| PEG Ratio | -0.3121 |
| Price to Book Value | 1.630 |
| Price to Free Cash Flow | 19.87 |
| Price | 29.72 |
| Earnings Yield | -2.57% |
| PEGY Ratio | -0.2559 |
| Operating PE Ratio | 129.35 |